> AstraZeneca ($AZN) Canada announced the approval and availability of FluMist Quadrivalent. Release
> Beijing-based Sinovac Dalian ($SVA) got approval from the China FDA to begin clinical trials of its varicella vaccine. Release
> Indian Immunologicals announced that its new $38 million facility to produce human and animal vaccines has begun operations. Story